StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a report published on Thursday morning. The brokerage issued a hold rating on the software maker’s stock.
Separately, Stephens raised their price target on shares of Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a research note on Friday, January 31st.
Check Out Our Latest Stock Report on Veradigm
Veradigm Price Performance
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
- Five stocks we like better than Veradigm
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- How to Invest in Biotech Stocks
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- How to Use the MarketBeat Excel Dividend Calculator
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
